Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiteXstream is a biotechnology company focused on developing highly effective, non-toxic solutions for controlling mites and other pests in both agricultural and human health contexts. The company's core technology utilizes a proprietary biopesticide formulation that targets the nervous systems of pests without harming beneficial insects or human tissue. In the healthcare space, MiteXstream is advancing treatments for conditions caused by parasitic mites, such as demodicosis, rosacea, and blepharitis. Their approach emphasizes environmental safety and the prevention of pesticide resistance, positioning them as a sustainable alternative to traditional chemical treatments. The company is currently transitioning its proven agricultural technology into clinical applications for human dermatology and ophthalmology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiteXstream.